Ozenci, V <br/><br/>
Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.  [electronic resource] 

 -  Clinical and experimental immunology  Apr 2000 
 - 147-53 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2249.2000.01175.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Humans<br/>Interferon-beta--therapeutic use<br/>Interferon-gamma--blood<br/>Interleukin-10--blood<br/>Interleukin-6--blood<br/>Leukocytes, Mononuclear--metabolism<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--blood<br/>Tumor Necrosis Factor-alpha--cerebrospinal fluid